Search research articles
Contact Us
Filters
Showing results (251-260 of 348) with videos related to
Page
of 35
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2015
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
John M Goldberg, David E Fisher, George D Demetri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2015
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Nicolas A Giraldo, Etienne Becht, Franck Pagès, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2023
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Liya Ding, Qiwei Wang, Antons Martincuks, et al.
Blood
|
September 14, 2013
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
Asim Saha, Kazutoshi Aoyama, Patricia A Taylor, et al.
Iscience
|
February 8, 2024
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model
Yufei Wang, Jae-Won Cho, Gabriella Kastrunes, et al.
Nature
|
March 26, 2026
Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustion
Christopher B Medina, Ewelina Sobierajska, Minghao Gong, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer
Xin Cheng, Changli Qian, Erica Holdridge, et al.
Cell Reports
|
December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
Liya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
Cancer Cell
|
September 13, 2017
Enhancing CD8<sup>+</sup> T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy
Ying Zhang, Raj Kurupati, Ling Liu, et al.
Page
of 35
Search research articles
Search
Showing results (251-260 of 348) with videos related to
Sort By:
Page
of 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2015
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
John M Goldberg, David E Fisher, George D Demetri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2015
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Nicolas A Giraldo, Etienne Becht, Franck Pagès, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2023
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Liya Ding, Qiwei Wang, Antons Martincuks, et al.
Blood
|
September 14, 2013
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
Asim Saha, Kazutoshi Aoyama, Patricia A Taylor, et al.
Iscience
|
February 8, 2024
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model
Yufei Wang, Jae-Won Cho, Gabriella Kastrunes, et al.
Nature
|
March 26, 2026
Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustion
Christopher B Medina, Ewelina Sobierajska, Minghao Gong, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer
Xin Cheng, Changli Qian, Erica Holdridge, et al.
Cell Reports
|
December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
Liya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
Cancer Cell
|
September 13, 2017
Enhancing CD8<sup>+</sup> T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy
Ying Zhang, Raj Kurupati, Ling Liu, et al.
Page
of 35